DNA methylation signatures provide novel diagnostic biomarkers and predict responses of immune therapy for breast cancer

Breast cancer (BRCA) is one of the most common malignant tumors affecting women worldwide. DNA methylation modifications can influence oncogenic pathways and provide potential diagnostic and therapeutic targets for precision oncology. In this study, we used non-parametric permutation tests to identi...

Full description

Bibliographic Details

Published in:	Frontiers in Genetics
Main Authors:	Zhishan Chen, Han Jiang, Qingqing Qin, Qiyuan Li, Liqing Hong
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2024-06-01
Subjects:	DNA methylation breast cancer prognosis signature immune therapy
Online Access:	https://www.frontiersin.org/articles/10.3389/fgene.2024.1403907/full